Good question as it is also explains why i've bought some shares.
Let me answer by saying - whilst i don't understand the technical details as to how/ why devices such as the microwave/ mobile/ etc works, i use these and find great utlility and value in them.
Similarly, I don't understand (or care to) how Wheezo works, but am encouraged that hospitals, doctors, telehealth and insurance providers find utility in this and are prepared to move it from the research/ trial stage to actually backing the technology. They could be backing them because they provide patient care, or it could be a ruse by insurance companies to lower their cost of operations by giving people devices and treating them outside the ED and in-patient systems - either way, I don't care. But the fact that they are backing a technology and process with $, some of which will come to RSH means that this value will see an increase in SP and hence value to me as an investor.
Therefore a punt to ride this until a better mousetrap comes along is a valid investment strategy. The new datapoints are that the FDA is providing $ via CPT codes. Major healthcare orgs and insurance co's are backing this and RSH has partnered into an eco-system that seems to have legs.
So i am in and now wait to see where this goes.If it goes nowhere as AlCp continues to opine using anecdotal evidence, then i move on. If it provides a return on my investment, then excellent.
Wish you all the best in punts/ investments where you hold shares as well.
RSH Price at posting:
4.9¢ Sentiment: None Disclosure: Held
